Sensors

Journal Browser

► Journal Browser

Biomedical Sensors for Diagnosis and Rehabilitation-2nd Edition

Share This Special Issue

Special Issue Information

Dear Colleagues,

According to the data provided by the World Health Organization, by 2030, one in six people in world will be aged 60 years or over. From a biological point of view, aging is a natural process where the cellules become damaged over time, increasing the risk of suffering several diseases. After acute trauma, rehabilitation therapy aims to recover these lost capabilities and restore the autonomy of the patients.

Cost-effective technologies that assist researchers and medical practitioners are needed. Biosensors are key elements in diagnosis and prognosis, and eventually, rehabilitation therapies. The medical society demands safe and cheaper means of performing their work in order to guarantee the sustainability of the entire healthcare system.

In general, biosensors can be applied to infection screening, early detection, chronic disease treatment, health management, and well-being surveillance. Moreover, some of them play an important role in rehabilitation. Physiological monitoring via biosensors could help in both the diagnosis and ongoing treatment of a huge number of individuals with neurological, cardiovascular, and pulmonary diseases, among others.

Prof. Dr. Cecilia Garcia
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Sensors is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Related Special Issue

Published Papers (1 paper)

Research

10 pages, 948 KiB

Open AccessArticle

Assessment of Temporal Somatosensory Discrimination in Females with Fibromyalgia: Reliability and Discriminative Ability of a New Assessment Tool

by Christophe Demoulin, Léonore Jodogne, Charline David, Jean-François Kaux and Marc Vanderthommen

Sensors 2024, 24(11), 3300; https://doi.org/10.3390/s24113300 - 22 May 2024

Viewed by 368

Abstract

We assessed the test–retest reliability and discriminative ability of a somatosensory temporal discrimination (SSTD) assessment tool for fibromyalgia syndrome (FMS) and determined if pain-related variables were associated with SSTD performance. Twenty-five women with FMS and twenty-five asymptomatic women were assessed during two sessions 7 to 10 days apart. The proportion of correct responses (range 0–100) was calculated. Sociodemographic information was collected for both groups. The participants with FMS also completed the widespread pain index and the Brief Pain Inventory. Test–retest reliability was verified by calculating intraclass correlation coefficients. Discriminative ability was verified by a between-group comparison of scores using a t-test. Associations between SSTD score and pain variables were tested using Pearson or Spearman correlation coefficients. The test–retest reliability of the SSTD score was excellent (ICC > 0.9, CI: 0.79–0.96) for the asymptomatic group and good for the FMS group (ICC: 0.81, 95% CI: 0.62–0.91). The median (Q1–Q3) test session SSTD score differed significantly between the FMS 84.1 (71–88) and the asymptomatic 91.6 (83.4–96.1) groups (p < 0.001). Only pain duration was associated with the SSTD score. In conclusion, the new SSTD test seems reliable for people with FMS and is discriminative. Further studies should examine its sensitivity to change and correlations with other SSTD tests. Full article

(This article belongs to the Special Issue Biomedical Sensors for Diagnosis and Rehabilitation-2nd Edition)

► Show Figures